Org.nr 915 108 598 AS · OSLO · 72.100 Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk Gaustadalléen 21, 0349 OSLO Latest filing: Årsregnskap 2025 · approved 26.06.2026 · journal 2026 605967 Analysis generated: 21 Aug 2026 · Auto-onboard

ABLY MEDICAL AS

ABLY MEDICAL AS · 12 published annual accounts (2014–2025). Latest year revenue 4.0m NOK, net result -21.8m NOK, equity 67.1m NOK, cash 6.2m NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R2014–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About 4.0m

Operating income / revenue in 2025.

Did they make money?
-21.8m

Net result for 2025.

What’s left in the company
Equity 67.1m

Book equity at year-end.

Cash
6.2m

Bank deposits and cash (when disclosed).

Key figures

Revenue / sales
3 968 913
NOK · [R2025]
Net result
-21 790 136
NOK · [R2025]
Equity
67 127 719
NOK · [R2025]
Cash
6 202 607
NOK · [R2025]
Total assets
108 576 998
NOK · [R2025]
Paid-in equity
78 732 441
NOK · [R2025]

12-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.